iSpecimen Inc. Information Technology and Data Processing
iSpecimen Inc. (ISPC) reported Information Technology and Data Processing of $290.23 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InformationTechnologyAndDataProcessing · last filed 2026-08-14
- iSpecimen Inc. information technology and data processing for the quarter ending 2026-06-30 was $290.23K, a 45.88% decline year-over-year.
- iSpecimen Inc. information technology and data processing for the quarter ending 2026-03-31 was $247.55K, a 54.61% decline year-over-year.
- iSpecimen Inc. information technology and data processing for the quarter ending 2025-12-31 was $527.03K, a 44.62% decline year-over-year.
- iSpecimen Inc. information technology and data processing for the quarter ending 2025-09-30 was $551.10K, a 26.98% decline year-over-year.
- iSpecimen Inc. information technology and data processing for fiscal 2025 was $2.16M, a 38.82% decline from fiscal 2024.
- iSpecimen Inc. information technology and data processing for fiscal 2024 was $3.53M.
| Period end | Information Technology and Data Processing 3 month | Information Technology and Data Processing 6 month | Information Technology and Data Processing 9 month | Information Technology and Data Processing 12 month |
|---|---|---|---|---|
| 2026-06-30 | $290.23K 10-Q · filed 2026-08-14 | $554.88K 10-Q · filed 2026-08-14 | $1.06M derived: sum of 3 quarters · filed 2026-08-14 | $1.62M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $247.55K 10-Q · filed 2026-05-18 | $774.58K derived: sum of 2 quarters · filed 2026-05-18 | $1.33M derived: sum of 3 quarters · filed 2026-05-18 | $1.86M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $527.03K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $1.08M derived: sum of 2 quarters · filed 2026-04-01 | $1.61M derived: sum of 3 quarters · filed 2026-08-14 | $2.16M 10-K · filed 2026-04-01 |
| 2025-09-30 | $551.10K 10-Q · filed 2025-11-17 | $1.09M derived: sum of 2 quarters · filed 2026-08-14 | $1.63M 10-Q · filed 2025-11-17 | $2.58M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $536.31K 10-Q · filed 2026-08-14 | $1.08M 10-Q · filed 2026-08-14 | $2.03M derived: sum of 3 quarters · filed 2026-08-14 | $2.79M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $545.37K 10-Q · filed 2026-05-18 | $1.50M derived: sum of 2 quarters · filed 2026-05-18 | $2.25M derived: sum of 3 quarters · filed 2026-05-18 | $3.16M derived: sum of 4 quarters · filed 2026-05-18 |
| 2024-12-31 | $951.67K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $1.71M derived: sum of 2 quarters · filed 2026-04-01 | $2.62M derived: sum of 3 quarters · filed 2026-04-01 | $3.53M 10-K · filed 2026-04-01 |
| 2024-09-30 | $754.73K 10-Q · filed 2025-11-17 | $1.67M derived: sum of 2 quarters · filed 2025-11-17 | $2.58M 10-Q · filed 2025-11-17 | |
| 2024-06-30 | $911.93K 10-Q · filed 2025-08-14 | $1.82M 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $911.97K 10-Q · filed 2025-05-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |